• When: Feb 1 2019 - 12:30pm

    Location: DHMC - Psychiatry - Silverfarb Conference Room

    Description: The SYNERGY Imaging Sciences Group and the Brain Imaging Lab in Dartmouth-Hitchcock Psychiatry will be hosting an imaging didactic series beginning in February 2019 (Friday, February 1 and selected Fridays thereafter through April 19). All sessions will meet from 12:30 to 2:00 p.m. in the Silberfarb conference room in Psychiatry. All those interested in imaging research are welcome to attend. We encourage advance signup via email to: The organizing focus is functional MR imaging of the brain, and consequently the first session will be an overview of fMRI imaging intended to help give a "big picture" that subsequent topic pieces can fit into. The planned schedule covers seven sessions:

    Didactic Schedule: Weekly sessions on Fridays February – April 2019 from 12:30 – 2:00 p.m.
    Date, Topic and Notes

    1 Feb: Introduction to topics, MRI/fMRI overview, intro to MRI safety screening
    15 Feb: MRI safety, Advanced Imaging Center Tour and mock patient visit (Safety pre-screen required)
    8 Mar: fMRI preprocessing
    22 Mar: The General Linear Model (GLM) and single subject fMRI analysis
    5 Apr: fMRI group level analysis and statistics
    12 Apr: BOLD and the biological basis of fMRI
    19 Apr: MRI physics and MRI acquisition
    The SYNERGY Imaging Sciences Group also provides individualized training, custom group didactics, and research consultations, and additional topics not covered in this series be announced separately following its completion (both participants and non-participants are therefore encouraged to give feedback on topics of interest). To contact us for any of these points, email

    ...more details
  • When: Feb 7 2019 - 8:00am

    Location: Natcher Auditorium, NIH campus, Bethesda, MD

    Description: This National Center for Advancing Translational Sciences (NCATS)-sponsored The Opioid Crisis and the Future of Addiction and Pain Therapeutics: Opportunities, Tools, and Technologies Symposium will highlight challenges and opportunities throughout the discovery and development process for addiction- and pain-related medications in the pre-competitive preclinical stage and provide a framework for more focused efforts within the research community. There has been a dramatic increase in individuals who abuse and subsequently become addicted to opiates. The current "opioid crisis" is now a public health burden resulting in deaths, debilitation and significant social and economic impact. The National Institutes of Health (NIH) Helping to End Addiction Long-term (HEAL) Initiative addresses multiple challenges, including the development of currently unavailable non-addictive pain medications, medical interventions for opioid overdose and new addiction treatments. The development of such medications requires concerted efforts among many researchers to enable the discovery and validation of new targets, pathways, biomarkers and therapeutic candidates. The success of such discoveries will rely heavily on the availability of biologically, physiologically and pharmacologically relevant reagents, assays, model systems and validated probe compounds that need to be both reproducible and highly predictive of efficacy in humans.

    ...more details